**Headline:** Zevra Therapeutics Shares New Data on MIPLYFFA® for Niemann-Pick Disease Type C at WORLDSymposium
Zevra Therapeutics has presented recent findings on the use of MIPLYFFA® in treating Niemann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium. The data, gathered from both real-world settings and clinical trials, demonstrate the long-term safety and effectiveness of MIPLYFFA® in pediatric and adult patients with NPC. The results …